1. Home
  2. RGEN vs MORN Comparison

RGEN vs MORN Comparison

Compare RGEN & MORN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • MORN
  • Stock Information
  • Founded
  • RGEN 1981
  • MORN 1984
  • Country
  • RGEN United States
  • MORN United States
  • Employees
  • RGEN N/A
  • MORN N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • MORN Investment Managers
  • Sector
  • RGEN Health Care
  • MORN Finance
  • Exchange
  • RGEN Nasdaq
  • MORN Nasdaq
  • Market Cap
  • RGEN 8.2B
  • MORN 9.0B
  • IPO Year
  • RGEN N/A
  • MORN 2005
  • Fundamental
  • Price
  • RGEN $142.30
  • MORN $214.61
  • Analyst Decision
  • RGEN Buy
  • MORN Strong Buy
  • Analyst Count
  • RGEN 11
  • MORN 3
  • Target Price
  • RGEN $170.90
  • MORN $333.33
  • AVG Volume (30 Days)
  • RGEN 1.0M
  • MORN 412.5K
  • Earning Date
  • RGEN 10-28-2025
  • MORN 10-29-2025
  • Dividend Yield
  • RGEN N/A
  • MORN 0.84%
  • EPS Growth
  • RGEN N/A
  • MORN 16.18
  • EPS
  • RGEN 0.03
  • MORN 8.80
  • Revenue
  • RGEN $707,890,000.00
  • MORN $2,395,400,000.00
  • Revenue This Year
  • RGEN $17.50
  • MORN $8.52
  • Revenue Next Year
  • RGEN $12.74
  • MORN $7.45
  • P/E Ratio
  • RGEN $4,625.69
  • MORN $24.50
  • Revenue Growth
  • RGEN 11.74
  • MORN 7.76
  • 52 Week Low
  • RGEN $102.97
  • MORN $202.89
  • 52 Week High
  • RGEN $182.52
  • MORN $365.00
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 44.45
  • MORN 41.83
  • Support Level
  • RGEN $144.18
  • MORN $206.68
  • Resistance Level
  • RGEN $151.25
  • MORN $215.75
  • Average True Range (ATR)
  • RGEN 6.92
  • MORN 5.86
  • MACD
  • RGEN -2.45
  • MORN 0.71
  • Stochastic Oscillator
  • RGEN 9.42
  • MORN 54.88

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About MORN Morningstar Inc.

Morningstar Inc is a provider of independent investment research to financial advisers, asset managers, and investors. The company focuses its operations on two core sectors: data and research. It offers data on investments such as mutual funds, stocks, exchange-traded funds, closed-end funds, separate accounts, and variable annuities. Further, the company tracks real-time market data of equity, derivative, currency exchanges, and other investments. In its research operation, Morningstar offers analyst research on passive and active mutual funds, alternative funds, and college saving plans. Morningstar's majority of the revenue is generated in the United States of America.

Share on Social Networks: